| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ginkgo Bioworks Holdings, Inc. (DNA) has 2 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. DNA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 24.3K | $222.9K | - | |
| Other | 7.5K | $68.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 4, 2024 | Dmytruk Mark E.78 | See Remarks | Sale+OE | 1,217 | $8.35 | $10,163.17 | -3.9% | +22.7% | +93.8% | |
| Oct 4, 2024 | Coen Steven P.70 | See Remarks | Sale+OE | 306 | $8.35 | $2,555.41 | -4.8% | +22.7% | +93.8% | |
| Sep 12, 2024 | Coen Steven P.70 | See Remarks | Sale+OE | 316 | $6.17 | $1,950.35 | -5.3% | +70.7% | +59.6% | |
| Sep 12, 2024 | Dmytruk Mark E.78 | See Remarks | Sale+OE | 1,148 | $6.17 | $7,085.46 | -3.8% | +70.7% | +59.6% | |
| Aug 2, 2024 | Coen Steven P.70 | See Remarks | Sale+OE | 17,486 | $0.29 | $5,018.48 | -7.8% | -39.4% | -3.1% | |
| Aug 2, 2024 | Dmytruk Mark E.78 | See Remarks | Sale+OE | 63,567 | $0.29 | $18,243.73 | -5.5% | -39.4% | -3.1% | |
| Jul 2, 2024 | Coen Steven P.70 | See Remarks | Sale+OE | 13,520 | $0.33 | $4,407.52 | -6.5% | -41.2% | -8.7% | |
| Jul 2, 2024 | Dmytruk Mark E.78 | See Remarks | Sale+OE | 49,162 | $0.33 | $16,026.81 | -4.5% | -41.2% | -8.7% | |
| Jun 3, 2024 | Dmytruk Mark E.78 | See Remarks | Sale+OE | 48,866 | $0.55 | $26,827.43 | -4.7% | -71.8% | -65.5% | |
| Jun 3, 2024 | Coen Steven P.70 | See Remarks | Sale+OE | 13,440 | $0.55 | $7,378.56 | -7.0% | -71.8% | -65.5% |